Organon Dermatology to present new Phase 3 analysis of VTAMA eczema data at the Society for Pediatric Dermatology annual meeting on July 23, 2026.
Opposition to AI infrastructure is crystallizing into a political force — the likes of which this province has seen before.
Spanish Mountain Gold Ltd. (the " Company " or " Spanish Mountain Gold ") (TSX-V: SPA) (FSE: S3Y) (OTCQB: SPAUF) is ple ...
The Sports Analytics Research Group employs quantitative analysis to give teams the hard numbers they need to perform better ...
Turn Therapeutics, Inc. (NASDAQ: TTRX), a clinical-stage biotechnology company developing targeted, non-systemic therapies for inflammatory skin diseases, today announced the completion of a ...
The recently launched Trump Accounts from President Donald Trump could drive almost $20 billion worth of inflows into U.S.
The inaugural season of the Gomezgil Yaspik Data Science Laboratory marks the beginning of a new chapter for for Bowdoin.
Oklo Inc. (NYSE: OKLO) ("Oklo"), an advanced nuclear technology company, today announced that the U.S. Department of Energy ...
6don MSN
Starting July 1, CT medical program using psychedelics opens to the public. There’s high demand
A new law taking effect Wednesday expands a Yale pilot program that uses psilocybin with structured therapy to treat ...
GS Retail held an AI transformation (AX) case-sharing event at GS Tower in Seoul's Yeoksam district on Monday, bringing ...
Tenax Therapeutics, Inc. downgraded to Hold ahead of Aug 2026 phase 3 TNX-103 data in PH-HFpEF; weigh 6MWD odds, downside, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results